Who owns Abbvie?
- CUSIP Number: 00287Y959
Tip: Access positions for across all investors
Analyze quarterly positions in Abbvie with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Abbvie stock
Who bought or sold Abbvie this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Jpmorgan Chase & Co | 796k | $157M | 155% | Sep 2024 |
|
Simplex Trading | 509k | $101M | 60% | Sep 2024 |
|
IMC-Chicago | 428k | $85M | 39% | Sep 2024 |
|
SG Americas Securities | 132k | $86k | 0% | Sep 2024 |
|
Group One Trading | 62k | $12M | 56% | Sep 2024 |
|
Gladius Capital Management | 31k | $6.1M | 72% | Sep 2024 |
|
Maven Securities | 22k | $3.8M | 100% | Jun 2024 |
|
Cantor Fitzgerald, L. P. | 10k | $2.0M | 100% | Sep 2024 |
|
Colony | 5.5k | $1.1M | 100% | Sep 2024 |
|
Hrt Financial | 3.3k | $651k | 100% | Sep 2024 |
|
Marathon Trading Investment Management | 200.00 | $40k | 100% | Sep 2024 |
|
Who sold out of Abbvie?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Jane Street | Jun 2024 | 568k | $97M |
National Bank Of Canada /fi/ | Jun 2024 | 3.1k | $53M |